CTRC
ENSG00000162438
Target class
Enzyme
Chromosome
1
- Chemical probe available
- No
- Target name
- CTRC
- Gene name
- Chymotrypsin C
- Gene symbol
- CTRC
- Protein name
- Chymotrypsin-C (EC 3.4.21.2) (Caldecrin)
- CLCR
- ELA4
- Gene biotype
- Protein coding
- Gene family
- Chymotrypsins
- Target class
- Enzyme
- Target type
- Human gene
- Tissues expressed in
- 1
- Highest tissue expression
- 3,339.98
- Tissue specificity (Gini)
- 0.978
- Tissue specificity (tau)
- 1
- KEGG gene identifiers
- hsa:11330
- Reactome pathways
- R-HSA-9925561
- Protein interaction confidence
- 0.807222
- Protein interaction partners
- 9
- End position
- 15449242
- Start position
- 15438442
- Chromosome
- 1
- Strand
- Forward
- Tissue specificity (tau)
- 0.999906
- Expression inequality (Gini)
- 0.978198
Expression in transcripts per million
- Pancreas
- 3,339.98
- Spleen
- 0.89
- Testis
- 0.72
- Cervix - Ectocervix
- 0.71
- Whole Blood
- 0.69
Expression in transcripts per million
- Pancreas3,339.98
- Spleen0.89
- Testis0.72
- Cervix - Ectocervix0.71
- Whole Blood0.69
- Fallopian Tube0.67
- Brain - Cerebellum0.52
- Uterus0.52
- Prostate0.52
- Ovary0.48
- Vagina0.47
- Lung0.47
- Pituitary0.44
- Bladder0.43
- Small Intestine - Terminal Ileum0.41
- Esophagus - Mucosa0.39
- Brain - Cerebellar Hemisphere0.38
- Stomach0.38
- Thyroid0.38
- Cervix - Endocervix0.37
- Adrenal Gland0.35
- Adipose - Subcutaneous0.33
- Skin - Not Sun Exposed (Suprapubic)0.32
- Skin - Sun Exposed (Lower leg)0.32
- Artery - Aorta0.32
And 29 more, listed on the interactive page.
- GO:0006508
- GO:0006874
- GO:0005515
- GO:0008233
Related records
Trials (26)
- A Study Evaluating Drug Drug Interaction Between Milvexian and Atorvastatin in Healthy Participants
- A Study of JNJ-70033093 (BMS-986177) in Healthy Adult Participants
- A Study of JNJ-70033093 (BMS-986177) in Healthy Chinese Adult Participants
- A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
- A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants
- A Study of JNJ-70033093 and Digoxin in Healthy Participants
- A Study of JNJ-70033093 in Healthy Participants
- A Study of Milvexian in Healthy Adult Females
- A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
- A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants
- A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
- A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
- A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
- A Study to Assess the Reversal of the Anticoagulant Effects of Milvexian by 4-Factor Prothrombin Complex Concentrate (4F-PCC) (Part 1) and Recombinant Human Factor VIIa (rFVIIa) (Part 2) in Healthy Participants
- A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis
- A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects
- A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects
- A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
- An Investigational Study to Assess the Effect of BMS-986177 on Aspirin in Healthy Participants